Results 131 to 140 of about 5,903 (227)

Impact of maintenance therapy with fluoropyrimidines in advanced esophageal-gastric adenocarcinoma: a retrospective study in Mexican population. [PDF]

open access: yesJ Gastrointest Oncol
Dip Borunda AK   +6 more
europepmc   +1 more source

PARG Governs a PARylation-Ubiquitination Toggle that Stabilizes RAD51AP1 to Drive Homologous Recombination-Mediated Chemoresistance. [PDF]

open access: yesCancer Res
He H   +24 more
europepmc   +1 more source

Genetic Variants Associated with Fluoropyrimidine-Induced Toxicity in Real-World Patients After Pre-Emptive <i>DPYD</i> Pharmacogenetic Testing. [PDF]

open access: yesPharmaceuticals (Basel)
Rodríguez-García M   +8 more
europepmc   +1 more source

A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas. [PDF]

open access: yesClin Cancer Res
Low JL   +13 more
europepmc   +1 more source

Uptake of DPYD and UGT1A1 testing in Italy and adherence to pharmacogenetic guidelines: A 5-year perspective from an EQA provider. [PDF]

open access: yesBr J Clin Pharmacol
Roncato R   +8 more
europepmc   +1 more source

Enhancement of Chemosensitivity to Fluoropyrimidines by Retroviral Transduction of Thymidine Phosphorylase cDNA: an in vitro and in vivo Study

open access: yes
Thymidine phospholyrase (TP) is an essential enzyme in activating 5’-deoxy-5-fluorocytidine (5’- DFUR) into 5-fluorouracil (5-FU) and for the conversion of 5-FU into 5-fluoro-2’-deoxyuridine.
MANOME, Yoshinobu   +3 more
core  

A Strategic Implementation Framework for Integrating Pharmacogenomics (PGx) into Personalized Healthcare in Saudi Arabia. [PDF]

open access: yesGenes (Basel)
Alrubaie KR   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy